Research field (3):
Pharmacology
, Neuroscience - general
, Neuroscience - general
Research keywords (9):
Brain imaging
, Behavioral analysis
, Cognitive function
, marmoset
, Primate
, Neuroscience
, Preclinical Study
, Parkinson's disease
, Neurodegenerative disease
Papers (65):
Ando K, Inoue T, Hikishima K, Komaki Y, Kawai K, Inoue R, Nishime C, Nishinaka E, Urano K, Okano H. Measurement of baseline locomotion and other behavioral traits in a common marmoset model of Parkinson's disease established by a single administration regimen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: providing reference data for efficacious precl. Behavioural pharmacology. 2020. 31. 1. 45-60
Kiyoshi Ando, Chiyoko Nishime, Ryo Inoue, Eiko Nishinaka, Kenji Kawai, Koji Urano, Hideki Tsutsumi. Differential effects of dopaminergic drugs on spontaneous motor activity in the common marmoset following pretreatment with a bilateral brain infusion of 6-hydroxydopamine. BEHAVIOURAL PHARMACOLOGY. 2017. 28. 8. 670-680
INAJI Motoki, MAEDA Jun, ANDO Kiyoshi, HIGUCHI Makoto, SUHARA Tetsuya, OKANO Hideyuki, NARIAI Tadashi, OHNO Kikuo. in vivo PET evaluation of fetal transplantation in unilaterally 6-OHDA lesioed rat. Functional neurosurgery : proceedings of the annual meeting of the Japan Society for Stereotactic and Functional Neurosurgery. 2006. 45. 1. 6-7
パーキンソン病モデル・マーモセットにおける in vivo イメージング検出による神経変性と行動的症候発現の相関
(第6回日本マーモセット研究会大会 2016)
Behavioral pharmacological effects of dopaminergic drugs in common marmosets pretreated with subcutaneous MPTP or intracerebral 6-OHDA
(The Society for Neuroscience 2014, Washington DC. 19 November 2014 2014)
Behavioral baseline of the MPTP-treated common marmoset in preclinical studies on Parkinson's disease.
(The Society for Neuroscience 2013, San Diego. 2013)
Measurement of cognitive function in the common marmoset using iPad.
(The 43th Annual Meeting of Japanese Society for Neuropsychopharmacology, Ginowan. 2013)
MPTP-induced Parkinson's disease model of the common marmoset as a guidepost and a stepping stone in developing neurodegenerative models in nonhuman primates.
(2013 KALAS International Symposium, Jeju island. 2013)